- Home
- JANX vs MTRN Comparison
JANX vs MTRN Comparison
Compare JANX & MTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- MTRN
- Stock Information
- Founded
- JANX 2017
- MTRN 1931
- Country
- JANX United States
- MTRN United States
- Employees
- JANX N/A
- MTRN N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- MTRN Industrial Specialties
- Sector
- JANX Health Care
- MTRN Industrials
- Exchange
- JANX Nasdaq
- MTRN Nasdaq
- Market Cap
- JANX 2.9B
- MTRN 2.4B
- IPO Year
- JANX 2021
- MTRN N/A
- Fundamental
- Price
- JANX $46.50
- MTRN $112.82
- Analyst Decision
- JANX Strong Buy
- MTRN Strong Buy
- Analyst Count
- JANX 10
- MTRN 2
- Target Price
- JANX $65.10
- MTRN $143.50
- AVG Volume (30 Days)
- JANX 637.5K
- MTRN 91.2K
- Earning Date
- JANX 11-06-2024
- MTRN 10-30-2024
- Dividend Yield
- JANX N/A
- MTRN 0.47%
- EPS Growth
- JANX N/A
- MTRN N/A
- EPS
- JANX N/A
- MTRN 3.54
- Revenue
- JANX $13,049,000.00
- MTRN $1,668,911,000.00
- Revenue This Year
- JANX $66.30
- MTRN $3.05
- Revenue Next Year
- JANX N/A
- MTRN $6.06
- P/E Ratio
- JANX N/A
- MTRN $32.30
- Revenue Growth
- JANX 54.12
- MTRN N/A
- 52 Week Low
- JANX $7.79
- MTRN $96.18
- 52 Week High
- JANX $65.60
- MTRN $145.08
- Technical
- Relative Strength Index (RSI)
- JANX 33.84
- MTRN 52.55
- Support Level
- JANX $47.04
- MTRN $109.28
- Resistance Level
- JANX $49.74
- MTRN $123.21
- Average True Range (ATR)
- JANX 2.88
- MTRN 3.40
- MACD
- JANX -1.00
- MTRN -0.41
- Stochastic Oscillator
- JANX 4.54
- MTRN 44.08
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.
About MTRN Materion Corporation
Materion Corp is a producer of engineered materials based in the United States. The company produces materials used in electrical, electronic, thermal, and structural applications. The company operates in four reportable segments: Performance Materials, Electronic Materials, Precision Optics, and Other. The majority of revenue is derived from Electronic Materials which produces chemicals, microelectronics packaging, precious metal, non-precious metal, and specialty metal products, including vapor deposition targets, frame lid assemblies, clad and precious metal pre-forms, high temperature braze materials, and ultra-pure wire.